{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T01:36:54Z","timestamp":1792805814244,"version":"4.5.0"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2008,10,21]],"date-time":"2008-10-21T00:00:00Z","timestamp":1224547200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Br J Cancer"],"published-print":{"date-parts":[[2008,11]]},"DOI":"10.1038\/sj.bjc.6604730","type":"journal-article","created":{"date-parts":[[2008,10,21]],"date-time":"2008-10-21T20:49:20Z","timestamp":1224622160000},"page":"1613-1622","source":"Crossref","is-referenced-by-count":11,"title":["Enhanced killing of androgen-independent prostate cancer cells using inositol hexakisphosphate in combination with proteasome inhibitors"],"prefix":"10.1038","volume":"99","author":[{"given":"J-S","family":"Diallo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B","family":"Betton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N","family":"Parent","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B","family":"P\u00e9ant","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L","family":"Lessard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C","family":"Le Page","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R","family":"Bertrand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A-M","family":"Mes-Masson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F","family":"Saad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2008,10,21]]},"reference":[{"issue":"5A","key":"BF6604730_CR1","first-page":"3855","volume":"23","author":"C Agarwal","year":"2003","unstructured":"Agarwal C, Dhanalakshmi S, Singh RP, Agarwal R . Inositol hexaphosphate inhibits constitutive activation of NF-kappa B in androgen-independent human prostate carcinoma DU145 cells. Anticancer Res (2003); 23 (5A): 3855\u20133861","journal-title":"Anticancer Res"},{"issue":"5","key":"BF6604730_CR2","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1593\/neo.04232","volume":"6","author":"C Agarwal","year":"2004","unstructured":"Agarwal C, Dhanalakshmi S, Singh RP, Agarwal R . Inositol hexaphosphate inhibits growth and induces G1 arrest and apoptotic death of androgen-dependent human prostate carcinoma LNCaP cells. Neoplasia (2004); 6 (5): 646\u2013659","journal-title":"Neoplasia"},{"issue":"7","key":"BF6604730_CR3","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1038\/ncb1427","volume":"8","author":"AR Alcazar-Roman","year":"2006","unstructured":"Alcazar-Roman AR, Tran EJ, Guo S, Wente SR . Inositol hexakisphosphate and Gle1 activate the DEAD-box protein Dbp5 for nuclear mRNA export. Nat Cell Biol (2006); 8 (7): 711\u2013716","journal-title":"Nat Cell Biol"},{"issue":"5203","key":"BF6604730_CR4","doi-asserted-by":"publisher","first-page":"1485","DOI":"10.1126\/science.7878466","volume":"267","author":"K Brown","year":"1995","unstructured":"Brown K, Gerstberger S, Carlson L, Franzoso G, Siebenlist U . Control of I kappa B-alpha proteolysis by site-specific, signal-induced phosphorylation. Science (1995); 267 (5203): 1485\u20131488","journal-title":"Science"},{"issue":"11","key":"BF6604730_CR5","doi-asserted-by":"publisher","first-page":"1769","DOI":"10.1016\/0006-2952(87)90236-X","volume":"36","author":"IJ Bruce","year":"1987","unstructured":"Bruce IJ, Kerry R . The effect of chloramphenicol and cycloheximide on platelet aggregation and protein synthesis. Biochem Pharmacol (1987); 36 (11): 1769\u20131773","journal-title":"Biochem Pharmacol"},{"issue":"53","key":"BF6604730_CR6","doi-asserted-by":"publisher","first-page":"55633","DOI":"10.1074\/jbc.M409825200","volume":"279","author":"H Buss","year":"2004","unstructured":"Buss H, D\u00f6rrie A, Schmitz ML, Hoffmann E, Resch K, Kracht M . Constitutive and interleukin-1-inducible phosphorylation of p65 NF-{kappa}B at serine 536 is mediated by multiple protein kinases including I{kappa}B kinase (IKK)-{alpha}, IKK{beta}, IKK{epsilon}, TRAF family member-associated (TANK)-binding kinase 1 (TBK1), and an unknown kinase and couples p65 to TATA-binding protein-associated factor II31-mediated interleukin-8 transcription. J Biol Chem (2004); 279 (53): 55633\u201355643","journal-title":"J Biol Chem"},{"issue":"5","key":"BF6604730_CR7","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1038\/nrm1368","volume":"5","author":"LF Chen","year":"2004","unstructured":"Chen LF, Greene WC . Shaping the nuclear action of NF-kappaB. Nat Rev Mol Cell Biol (2004); 5 (5): 392\u2013401","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"12","key":"BF6604730_CR8","doi-asserted-by":"publisher","first-page":"1681","DOI":"10.1038\/sj.onc.1209974","volume":"26","author":"CG Concannon","year":"2007","unstructured":"Concannon CG, Koehler BF, Reimertz C, Murphy BM, Bonner C, Thurow N, Ward MW, Villunger A, Strasser A, K\u00f6gel D, Prehn JH . Apoptosis induced by proteasome inhibition in cancer cells: predominant role of the p53\/PUMA pathway. Oncogene (2007); 26 (12): 1681\u20131692","journal-title":"Oncogene"},{"issue":"12","key":"BF6604730_CR9","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.1002\/pros.20455","volume":"66","author":"JS Diallo","year":"2006","unstructured":"Diallo JS, P\u00e9ant B, Lessard L, Delvoye N, Le Page C, Mes-Masson AM, Saad F . An androgen-independent androgen receptor function protects from inositol hexakisphosphate toxicity in the PC3\/PC3(AR) prostate cancer cell lines. Prostate (2006); 66 (12): 1245\u20131256","journal-title":"Prostate"},{"issue":"18 Part 2","key":"BF6604730_CR10","doi-asserted-by":"publisher","first-page":"6382S","DOI":"10.1158\/1078-0432.CCR-050008","volume":"10","author":"JP Dutcher","year":"2004","unstructured":"Dutcher JP . Mammalian target of rapamycin inhibition. Clin Cancer Res (2004); 10 (18 Part 2): 6382S\u20136387S","journal-title":"Clin Cancer Res"},{"issue":"12","key":"BF6604730_CR11","doi-asserted-by":"publisher","first-page":"2031","DOI":"10.1093\/carcin\/23.12.2031","volume":"23","author":"S Ferry","year":"2002","unstructured":"Ferry S, Matsuda M, Yoshida H, Hirata M . Inositol hexakisphosphate blocks tumor cell growth by activating apoptotic machinery as well as by inhibiting the Akt\/NFkappaB-mediated cell survival pathway. Carcinogenesis (2002); 23 (12): 2031\u20132041","journal-title":"Carcinogenesis"},{"issue":"4","key":"BF6604730_CR12","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1016\/S0965-2299(02)00092-4","volume":"10","author":"CH Fox","year":"2002","unstructured":"Fox CH, Eberl M . Phytic acid (IP6), novel broad spectrum anti-neoplastic agent: a systematic review. Complement Ther Med (2002); 10 (4): 229\u2013234","journal-title":"Complement Ther Med"},{"issue":"20","key":"BF6604730_CR13","doi-asserted-by":"publisher","first-page":"10976","DOI":"10.1073\/pnas.96.20.10976","volume":"96","author":"M Groll","year":"1999","unstructured":"Groll M, Heinemeyer W, J\u00e4ger S, Ullrich T, Bochtler M, Wolf DH, Huber R . The catalytic sites of 20S proteasomes and their role in subunit maturation: a mutational and crystallographic study. Proc Natl Acad Sci USA (1999); 96 (20): 10976\u201310983","journal-title":"Proc Natl Acad Sci USA"},{"issue":"5596","key":"BF6604730_CR14","doi-asserted-by":"publisher","first-page":"1241","DOI":"10.1126\/science.1071914","volume":"298","author":"A Hoffmann","year":"2002","unstructured":"Hoffmann A, Levchenko A, Scott ML, Baltimore D . The IkappaB-NF-kappaB signaling module: temporal control and selective gene activation. Science (2002); 298 (5596): 1241\u20131245","journal-title":"Science"},{"issue":"1","key":"BF6604730_CR15","doi-asserted-by":"publisher","first-page":"43","DOI":"10.3322\/canjclin.57.1.43","volume":"57","author":"A Jemal","year":"2007","unstructured":"Jemal A, Siegel R, Ward E, Murray T, Xu J, Thun MJ . Cancer statistics, 2007. CA Cancer J Clin (2007); 57 (1): 43\u201366","journal-title":"CA Cancer J Clin"},{"issue":"5","key":"BF6604730_CR16","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1016\/j.molcel.2007.04.019","volume":"26","author":"P Kamenski","year":"2007","unstructured":"Kamenski P, Kolesnikova O, Jubenot V, Entelis N, Krasheninnikov IA, Martin RP, Tarassov I . Evidence for an adaptation mechanism of mitochondrial translation via tRNA import from the cytosol. Mol Cell (2007); 26 (5): 625\u2013637","journal-title":"Mol Cell"},{"key":"BF6604730_CR17","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1146\/annurev.immunol.18.1.621","volume":"18","author":"M Karin","year":"2000","unstructured":"Karin M, Ben-Neriah Y . Phosphorylation meets ubiquitination: the control of NF-[kappa]B activity. Annu Rev Immunol (2000); 18: 621\u2013663","journal-title":"Annu Rev Immunol"},{"issue":"4","key":"BF6604730_CR18","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1038\/nrc780","volume":"2","author":"M Karin","year":"2002","unstructured":"Karin M, Cao Y, Greten FR, Li ZW . NF-kappaB in cancer: from innocent bystander to major culprit. Nat Rev Cancer (2002); 2 (4): 301\u2013310","journal-title":"Nat Rev Cancer"},{"issue":"12","key":"BF6604730_CR19","doi-asserted-by":"publisher","first-page":"1348","DOI":"10.1038\/ncb1499","volume":"8","author":"H Kim","year":"2006","unstructured":"Kim H, Rafiuddin-Shah M, Tu HC, Jeffers JR, Zambetti GP, Hsieh JJ, Cheng EH . Hierarchical regulation of mitochondrion-dependent apoptosis by BCL-2 subfamilies. Nat Cell Biol (2006); 8 (12): 1348\u20131358","journal-title":"Nat Cell Biol"},{"issue":"1","key":"BF6604730_CR20","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1152\/physrev.00013.2006","volume":"87","author":"G Kroemer","year":"2007","unstructured":"Kroemer G, Galluzzi L, Brenner C . Mitochondrial membrane permeabilization in cell death. Physiol Rev (2007); 87 (1): 99\u2013163","journal-title":"Physiol Rev"},{"issue":"10","key":"BF6604730_CR21","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1016\/S0962-8924(98)01346-4","volume":"8","author":"DH Lee","year":"1998","unstructured":"Lee DH, Goldberg AL . Proteasome inhibitors: valuable new tools for cell biologists. Trends Cell Biol (1998); 8 (10): 397\u2013403","journal-title":"Trends Cell Biol"},{"issue":"5","key":"BF6604730_CR22","doi-asserted-by":"publisher","first-page":"3130","DOI":"10.4049\/jimmunol.166.5.3130","volume":"166","author":"V Marshansky","year":"2001","unstructured":"Marshansky V, Wang X, Bertrand R, Luo H, Duguid W, Chinnadurai G, Kanaan N, Vu MD, Wu J . Proteasomes modulate balance among proapoptotic and antiapoptotic Bcl-2 family members and compromise functioning of the electron transport chain in leukemic cells. J Immunol (2001); 166 (5): 3130\u20133142","journal-title":"J Immunol"},{"issue":"3","key":"BF6604730_CR23","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1158\/1535-7163.MCT-04-0260","volume":"4","author":"M Nikrad","year":"2005","unstructured":"Nikrad M, Johnson T, Puthalalath H, Coultas L, Adams J, Kraft AS . The proteasome inhibitor bortezomib sensitizes cells to killing by death receptor ligand TRAIL via BH3-only proteins Bik and Bim. Mol Cancer Ther (2005); 4 (3): 443\u2013449","journal-title":"Mol Cancer Ther"},{"issue":"20","key":"BF6604730_CR24","doi-asserted-by":"publisher","first-page":"7345","DOI":"10.1128\/MCB.00126-06","volume":"26","author":"A Panner","year":"2006","unstructured":"Panner A, Nakamura JL, Parsa AT, Rodriguez-Viciana P, Berger MS, Stokoe D, Pieper RO . mTOR-independent translational control of the extrinsic cell death pathway by RalA. Mol Cell Biol (2006); 26 (20): 7345\u20137357","journal-title":"Mol Cell Biol"},{"issue":"5","key":"BF6604730_CR25","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1016\/S0092-8674(94)90482-0","volume":"78","author":"VJ Palombella","year":"1994","unstructured":"Palombella VJ, Rando OJ, Goldberg AL, Maniatis T . The ubiquitin\u2013proteasome pathway is required for processing the NF-kappa B1 precursor protein and the activation of NF-kappa B. Cell (1994); 78 (5): 773\u2013785","journal-title":"Cell"},{"issue":"11","key":"BF6604730_CR26","doi-asserted-by":"publisher","first-page":"2108","DOI":"10.1200\/JCO.2004.02.106","volume":"22","author":"CN Papandreou","year":"2004","unstructured":"Papandreou CN, Daliani DD, Nix D, Yang H, Madden T, Wang X, Pien CS, Millikan RE, Tu SM, Pagliaro L, Kim J, Adams J, Elliott P, Esseltine D, Petrusich A, Dieringer P, Perez C, Logothetis CJ . Phase I trial of the proteasome inhibitor bortezomib in patients with advanced solid tumors with observations in androgen-independent prostate cancer. J Clin Oncol (2004); 22 (11): 2108\u20132121","journal-title":"J Clin Oncol"},{"issue":"15","key":"BF6604730_CR27","doi-asserted-by":"publisher","first-page":"5036","DOI":"10.1158\/0008-5472.CAN-03-2707","volume":"64","author":"CN Papandreou","year":"2004","unstructured":"Papandreou CN, Logothetis CJ . Bortezomib as a potential treatment for prostate cancer. Cancer Res (2004); 64 (15): 5036\u20135043","journal-title":"Cancer Res"},{"issue":"9","key":"BF6604730_CR28","doi-asserted-by":"publisher","first-page":"e45","DOI":"10.1093\/nar\/29.9.e45","volume":"29","author":"MW Pfaffl","year":"2001","unstructured":"Pfaffl MW . A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res (2001); 29 (9): e45","journal-title":"Nucleic Acids Res"},{"issue":"3","key":"BF6604730_CR29","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/S1540-0352(11)70076-2","volume":"3","author":"N Price","year":"2004","unstructured":"Price N, Dreicer R . Phase I\/II trial of bortezomib plus docetaxel in patients with advanced androgen-independent prostate cancer. Clin Prostate Cancer (2004); 3 (3): 141\u2013143","journal-title":"Clin Prostate Cancer"},{"issue":"19","key":"BF6604730_CR30","doi-asserted-by":"publisher","first-page":"9636","DOI":"10.1158\/0008-5472.CAN-06-0747","volume":"66","author":"JZ Qin","year":"2006","unstructured":"Qin JZ, Xin H, Sitailo LA, Denning MF, Nickoloff BJ . Enhanced killing of melanoma cells by simultaneously targeting Mcl-1 and NOXA. Cancer Res (2006); 66 (19): 9636\u20139645","journal-title":"Cancer Res"},{"issue":"1","key":"BF6604730_CR31","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/S0014-5793(97)00669-8","volume":"411","author":"S Salvioli","year":"1997","unstructured":"Salvioli S, Ardizzoni A, Franceschi C, Cossarizza A . JC-1, but not DiOC6(3) or rhodamine 123, is a reliable fluorescent probe to assess delta psi changes in intact cells: implications for studies on mitochondrial functionality during apoptosis. FEBS Lett (1997); 411 (1): 77\u201382","journal-title":"FEBS Lett"},{"issue":"2","key":"BF6604730_CR32","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1006\/cimm.1996.1061","volume":"175","author":"SR Schow","year":"1997","unstructured":"Schow SR, Joly A . N-acetyl-leucinyl-leucinyl-norleucinal inhibits lipopolysaccharide-induced NF-kappaB activation and prevents TNF and IL-6 synthesis in vivo. Cell Immunol (1997); 175 (2): 199\u2013202","journal-title":"Cell Immunol"},{"issue":"3","key":"BF6604730_CR33","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1093\/carcin\/24.3.555","volume":"24","author":"RP Singh","year":"2003","unstructured":"Singh RP, Agarwal C, Agarwal R . Inositol hexaphosphate inhibits growth, and induces G1 arrest and apoptotic death of prostate carcinoma DU145 cells: modulation of CDKI-CDK-cyclin and pRb-related protein\u2013E2F complexes. Carcinogenesis (2003); 24 (3): 555\u2013563","journal-title":"Carcinogenesis"},{"issue":"1 Part 1","key":"BF6604730_CR34","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1158\/1078-0432.CCR-1080-3","volume":"10","author":"RP Singh","year":"2004","unstructured":"Singh RP, Sharma G, Mallikarjuna GU, Dhanalakshmi S, Agarwal C, Agarwal R . In vivo suppression of hormone-refractory prostate cancer growth by inositol hexaphosphate: induction of insulin-like growth factor binding protein-3 and inhibition of vascular endothelial growth factor. Clin Cancer Res (2004); 10 (1 Part 1): 244\u2013250","journal-title":"Clin Cancer Res"},{"issue":"5103","key":"BF6604730_CR35","doi-asserted-by":"publisher","first-page":"1912","DOI":"10.1126\/science.8096091","volume":"259","author":"SC Sun","year":"1993","unstructured":"Sun SC, Ganchi PA, Ballard DW, Greene WC . NF-kappa B controls expression of inhibitor I kappa B alpha: evidence for an inducible autoregulatory pathway. Science (1993); 259 (5103): 1912\u20131915","journal-title":"Science"},{"issue":"9","key":"BF6604730_CR36","doi-asserted-by":"publisher","first-page":"3848","DOI":"10.1091\/mbc.e03-02-0074","volume":"14","author":"J Sylvestre","year":"2003","unstructured":"Sylvestre J, Margeot A, Jacq C, Dujardin G, Corral-Debrinski M . The role of the 3\u2032 untranslated region in mRNA sorting to the vicinity of mitochondria is conserved from yeast to human cells. Mol Biol Cell (2003); 14 (9): 3848\u20133856","journal-title":"Mol Biol Cell"},{"issue":"10","key":"BF6604730_CR37","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1016\/0968-0004(93)90090-A","volume":"18","author":"K Verner","year":"1993","unstructured":"Verner K . Co-translational protein import into mitochondria: an alternative view. Trends Biochem Sci (1993); 18 (10): 366\u2013371","journal-title":"Trends Biochem Sci"},{"issue":"11 Suppl 1","key":"BF6604730_CR38","doi-asserted-by":"publisher","first-page":"3778S","DOI":"10.1093\/jn\/133.11.3778S","volume":"133","author":"I Vucenik","year":"2003","unstructured":"Vucenik I, Shamsuddin AM . Cancer inhibition by inositol hexaphosphate (IP6) and inositol: from laboratory to clinic. J Nutr (2003); 133 (11 Suppl 1): 3778S\u20133784S","journal-title":"J Nutr"},{"issue":"7","key":"BF6604730_CR39","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1038\/ncb1424","volume":"8","author":"CS Weirich","year":"2006","unstructured":"Weirich CS, Erzberger JP, Flick JS, Berger JM, Thorner J, Weis K . Activation of the DExD\/H-box protein Dbp5 by the nuclear-pore protein Gle1 and its coactivator InsP6 is required for mRNA export. Nat Cell Biol (2006); 8 (7): 668\u2013676","journal-title":"Nat Cell Biol"},{"issue":"6","key":"BF6604730_CR40","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1016\/j.ceb.2005.10.001","volume":"17","author":"SN Willis","year":"2005","unstructured":"Willis SN, Adams JM . Life in the balance: how BH3-only proteins induce apoptosis. Curr Opin Cell Biol (2005); 17 (6): 617\u2013625","journal-title":"Curr Opin Cell Biol"},{"issue":"Part 2","key":"BF6604730_CR41","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1099\/0022-1317-51-2-255","volume":"51","author":"N Yamamoto","year":"1980","unstructured":"Yamamoto N, Mueller-Lantzsch N, zur Hausen H . Effect of actinomycin D and cycloheximide on Epstein\u2013Barr virus early antigen induction in lymphoblastoid cells. J Gen Virol (1980); 51 (Part 2): 255\u2013261","journal-title":"J Gen Virol"},{"key":"BF6604730_CR42","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1007\/978-3-540-46091-6_14","volume":"176","author":"I Zavrski","year":"2007","unstructured":"Zavrski I, Jakob C, Kaiser M, Fleissner C, Heider U, Sezer O . Molecular and clinical aspects of proteasome inhibition in the treatment of cancer. Recent Results Cancer Res (2007); 176: 165\u2013176","journal-title":"Recent Results Cancer Res"},{"issue":"31","key":"BF6604730_CR43","doi-asserted-by":"publisher","first-page":"4993","DOI":"10.1038\/sj.onc.1208683","volume":"24","author":"H Zhu","year":"2005","unstructured":"Zhu H, Zhang L, Dong F, Guo W, Wu S, Teraishi F, Davis JJ, Chiao PJ, Fang B . Bik\/NBK accumulation correlates with apoptosis-induction by bortezomib (PS-341, Velcade) and other proteasome inhibitors. Oncogene (2005); 24 (31): 4993\u20134999","journal-title":"Oncogene"},{"issue":"7","key":"BF6604730_CR44","doi-asserted-by":"publisher","first-page":"1085","DOI":"10.1016\/j.cell.2005.06.009","volume":"121","author":"Q Zhong","year":"2005","unstructured":"Zhong Q, Gao W, Du F, Wang X . Mule\/ARF-BP1, a BH3-only E3 ubiquitin ligase, catalyzes the polyubiquitination of Mcl-1 and regulates apoptosis. Cell (2005); 121 (7): 1085\u20131095","journal-title":"Cell"},{"issue":"12","key":"BF6604730_CR45","doi-asserted-by":"publisher","first-page":"2225","DOI":"10.1093\/carcin\/21.12.2225","volume":"21","author":"X Zi","year":"2000","unstructured":"Zi X, Singh RP, Agarwal R . Impairment of erbB1 receptor and fluid-phase endocytosis and associated mitogenic signaling by inositol hexaphosphate in human prostate carcinoma DU145 cells. Carcinogenesis (2000); 21 (12): 2225\u20132235","journal-title":"Carcinogenesis"}],"container-title":["British Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/6604730.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/6604730","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/6604730.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T12:36:21Z","timestamp":1684413381000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/6604730"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,10,21]]},"references-count":45,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2008,11]]}},"alternative-id":["BF6604730"],"URL":"https:\/\/doi.org\/10.1038\/sj.bjc.6604730","relation":{},"ISSN":["0007-0920","1532-1827"],"issn-type":[{"value":"0007-0920","type":"print"},{"value":"1532-1827","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,10,21]]}}}